Regional variation in CCR5-Δ32 gene distribution among women from the USHIV Epidemiology Research Study (HERS)

被引:10
作者
Downer, MV
Hodge, T
Smith, DK
Qari, SH
Schuman, P
Mayer, KH
Klein, RS
Vlahov, D
Gardner, LI
McNicholl, JM
机构
[1] Ctr Dis Control & Prevent, Div AIDS STD & TB Lab Res, Natl Ctr Infect Dis, Immunogenet Lab, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA
[3] Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI USA
[4] Brown Univ, Div Infect Dis, Dept Med, Providence, RI 02912 USA
[5] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA
[6] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA
[7] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA
关键词
chemokine receptor; regional difference; black/African American; HIV-1; infection;
D O I
10.1038/sj.gene.6363884
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The CCR5-Delta32 genotype is known to influence HIV-1 transmission and disease. We genotyped 1301 US women of various races/ethnicities participating in the HIV Epidemiologic Research Study. None was homozygous for CCR5Delta32. The distribution of heterozygotes was similar in HIV-1 infected and uninfected women. Thirty-seven (11.8%) white, 28 (3.7%) blacks/African Americans (AA), seven (3.3%) Hispanics/Latinas, and one (6.6%) other race/ethnicity were heterozygous. The frequency of heterozygotes differed among sites for all races combined (P = 0.001). More heterozygotes were found in AA women in Rhode Island (8.9%) than in the other sites (3.1%) (P = 0.02), while heterozygosity in white women was most common in Maryland (28.6%) (P = 0.025). These regional differences could be accounted for by racial admixture in AAs, but not in whites. Regional variations should be considered when studying host genetic factors and HIV-1 in US populations.
引用
收藏
页码:295 / 298
页数:4
相关论文
共 24 条
[1]  
ACTON RT, 1993, TRANSPLANT P, V25, P2404
[2]  
BURGER H, 2000, 13 INT AIDS C DURB S
[3]   Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J].
Dean, M ;
Carrington, M ;
Winkler, C ;
Huttley, GA ;
Smith, MW ;
Allikmets, R ;
Goedert, JJ ;
Buchbinder, SP ;
Vittinghoff, E ;
Gomperts, E ;
Donfield, S ;
Vlahov, D ;
Kaslow, R ;
Saah, A ;
Rinaldo, C ;
Detels, R ;
OBrien, SJ .
SCIENCE, 1996, 273 (5283) :1856-1862
[4]  
Elharti E, 2000, AIDS RES HUM RETROV, V16, P87
[5]   Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals [J].
EugenOlsen, J ;
Iversen, AKN ;
Garred, P ;
Koppelhus, U ;
Pedersen, C ;
Benfield, TL ;
Sorensen, AM ;
Katzenstein, T ;
Dickmeiss, E ;
Gerstoft, J ;
Skinhoj, P ;
Svejgaard, A ;
Nielsen, JO ;
Hofmann, B .
AIDS, 1997, 11 (03) :305-310
[6]  
GJERTSON DW, 1998, HLA 1998, P231
[7]   PERFORMING THE EXACT TEST OF HARDY-WEINBERG PROPORTION FOR MULTIPLE ALLELES [J].
GUO, SW ;
THOMPSON, EA .
BIOMETRICS, 1992, 48 (02) :361-372
[8]   The role of a mutant CCR5 allele in HIV-1 transmission and disease progression [J].
Huang, YX ;
Paxton, WA ;
Wolinsky, SM ;
Neumann, AU ;
Zhang, LQ ;
He, T ;
Kang, S ;
Ceradini, D ;
Jin, ZQ ;
Yazdanbakhsh, K ;
Kunstman, K ;
Erickson, D ;
Dragon, E ;
Landau, NR ;
Phair, J ;
Ho, DD ;
Koup, RA .
NATURE MEDICINE, 1996, 2 (11) :1240-1243
[9]  
Kokkotou E, 1998, J Hum Virol, V1, P469
[10]   Frequency of CCR5 genotypes in HIV-infected patients in Roraima, Brazil [J].
Guerra Corado, Andre de Lima ;
Villarouco da Silva, George Allan ;
Carvalho Leao, Renato Augusto ;
Granja, Fabiana ;
Naveca, Felipe Gomes .
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2016, 20 (03) :314-315